Skip to content

Type 2 Diabetes and Exercise - A Pilot Study

Understanding the Acute Effects of Prolonged Sedentary Behaviour (Sitting) on Post-meal Glucose and Lipids - A Pilot Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00666861
Enrollment
2
Registered
2008-04-25
Start date
2008-04-30
Completion date
2008-11-30
Last updated
2009-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Brief summary

A randomised, cross-over trial targeting a small sample of older (age 45-65 years) overweight adults with type 2 diabetes the aims of this pilot study are to: 1. Determine the feasibility of investigating the acute effects of prolonged sedentary behaviour (sitting) in this target group. 2. Compare the acute effects of a single prolonged (8 hour) bout of sedentary behaviour (sitting) on glucose and triglyceride concentrations and key muscle and adipose regulatory enzymes to a similar bout of sedentary behaviour combined with intermittent bouts of light-intensity activity.

Detailed description

The proposed study will involve a randomised cross-over experimental trial conducted in the laboratory setting in older overweight adults with type 2 diabetes. Participants will receive both of the acute testing conditions in a randomised manner. Study design: Randomised cross-over pilot trial of 20 overweight/obese older adults with diet-controlled type 2 diabetes involving 2 acute treatment conditions, with a one-week wash-out period between testing conditions (Figure 1 a). Setting: Acute, supervised laboratory setting within the Alfred and Baker Heart Institute Medical Unit. Outcomes: We will measure acute responses in laboratory-measured plasma glucose & triglyceride levels (every 60 mins) and glucose concentrations determined from continuous glucose monitoring (CGMS).

Interventions

None listed

Sponsors

International Diabetes Institute, Australia
CollaboratorOTHER
Baker Heart Research Institute
CollaboratorOTHER
Bayside Health
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Diet controlled Diabetes 2. Overweight (BMI \> 27 kg/m2 but \<50 kg/m2)

Exclusion criteria

1. Hypoglycaemic Agents 2. Lipid Lowering Agents

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026